Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Agneta

Agneta Nordholm, Ojersjoe SE

Patent application numberDescriptionPublished
20100086580MEDICAL DEVICE WITH CONTROLLABLY RELEASABLE ANTIBACTERIAL AGENT - There is disclosed a medical device, such as a urinary catheter, comprising a substrate material, a hydrophilic surface coating, e.g. comprising polyvinylpyrrolidone (PVP), arranged on at least a part of the surface of said substrate material, and an antibacterial layer comprising oligodynamic metal arranged between the substrate material and the hydrophilic surface coating. Further, the hydrophilic surface coating has a thickness large enough to provide a controlled release of oligodynamic metal ions through the hydrophilic surface coating, such as a thickness when dry that exceeds 3 μm. Hereby, the variation in the release of the oligodynamic metal ions is significantly reduced, enabling an improved control of the release. A corresponding method is also disclosed.04-08-2010

Agneta Nordholm, Ojersjo SE

Patent application numberDescriptionPublished
20090101531Catheter receptacle provided with an antimicrobial compound - A catheter assembly (04-23-2009

Agneta Ohlström, Jarlasa SE

Patent application numberDescriptionPublished
20090308470SPINNER HOME SEQUENCE - The present invention relates to a method for determining the identity of a microfluidic device and a home position by means of a set of home position marks on the microfluidic device, which is of the type used in a microfluidic system. Said method comprises following phases: a microfluidic device scanning phase, wherein a microfluidic device is scanned for mark identifiers; a microfluidic device identifying phase, wherein at least one a characteristic feature of the set of home marks is/are determined and used for identifying the identity of the microfluidic device; a home position determining phase, wherein the home position is determined by the use of at least a subset of the home position marks identified during said previous phases. The present invention relates to a set of home marks, a microfluidic device carrying such a set of home marks, a microfluidic system, a computer program product and a computer program on a computer usable medium.12-17-2009

Agneta Ohlström, Jarlasa SE

Patent application numberDescriptionPublished
20090308470SPINNER HOME SEQUENCE - The present invention relates to a method for determining the identity of a microfluidic device and a home position by means of a set of home position marks on the microfluidic device, which is of the type used in a microfluidic system. Said method comprises following phases: a microfluidic device scanning phase, wherein a microfluidic device is scanned for mark identifiers; a microfluidic device identifying phase, wherein at least one a characteristic feature of the set of home marks is/are determined and used for identifying the identity of the microfluidic device; a home position determining phase, wherein the home position is determined by the use of at least a subset of the home position marks identified during said previous phases. The present invention relates to a set of home marks, a microfluidic device carrying such a set of home marks, a microfluidic system, a computer program product and a computer program on a computer usable medium.12-17-2009

Agneta Richter-Dahlfors, Saltsjo-Boo SE

Patent application numberDescriptionPublished
20100255557ELECTRICALLY CONTROLLED ION TRANSPORT DEVICE - A device for electrically controlled transport of ions between a source and a target electrolyte, including: a first source electrode and a first target electrode, each capable of conducting ions and electrons, wherein the source electrode is arranged to receive ions from the source electrolyte and the target electrode is arranged to release ions to the target electrolyte.10-07-2010
20110105997ELECTRICALLY CONTROLLED ION TRANSPORT DEVICE - A device for electrically controlled of ions, comprises a first electrolyte; a first electrode, which is arranged in direct or indirect contact with the first electrolyte, an encapsulation; and an ion conductor, which is arranged to receive and/or deliver ions from/to the first electrolyte. The encapsulation is arranged to effectively enclose the first electrolyte, and the ion conductor is arranged to transport ions from/to an outside of the encapsulation.05-05-2011

Patent applications by Agneta Richter-Dahlfors, Saltsjo-Boo SE

Agneta Siegbahn, Uppsala SE

Patent application numberDescriptionPublished
20090036378Use of Factor VIIa or a Tissue Factor Antagonist for Regulating Gene Expression and Cell Migration or Chemotaxis - The present invention relates to use of FVII and/or FVIIa and/or another TF agonist and/or FVIIai and/or another TF antagonist in therapeutic treatment of pathological conditions that can be related to cell migration or treated by specific regulation of cell migration or chemotaxis.02-05-2009

Patent applications by Agneta Siegbahn, Uppsala SE